Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TURGEX is a topical emulsion formulation of hexachlorophene, a broad-spectrum antimicrobial agent used historically for skin antisepsis and wound cleansing. The drug works through disruption of bacterial cell membranes via chlorine interaction with lipid and protein components. This NDA product is currently in pre-launch stage under R-Pharm US sponsorship.
Pre-Launch
Pre-launch stage presents opportunity to build commercial infrastructure from ground zero; team size and budget allocation will depend on regulatory approval timeline and market entry strategy.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Why This Matters for Your Career
R-Pharm US is hiring 4 roles related to this product
Worked on TURGEX at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.